CONMED Corp. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€106.18
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.97%. Dividends of €0.74 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | -10.857% | -10.857% | -53.778% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten